Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.
Publisher’s analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.
Complete Report Available at http://www.reportsweb.com/global-antipsychotic-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Publisher’s report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson
Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001830867/sample .
Other prominent vendors
• Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
• Alkermes
• Bristol-Myers Squibb
Market driver
• Increasing expenditure on prescription drugs
• For a full, detailed list, view our report
Market challenge
• Lack of standard diagnostic methods
• For a full, detailed list, view our report
Market trend
• Rising public interest toward mental health
• For a full, detailed list, view our report
Inquire about Report at: http://www.reportsweb.com/inquiry&RW0001830867/buying .
Table of Contents:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Key clinical trials
PART 07: Market landscape
PART 08: Market segmentation by disease type
PART 09: Market segmentation based on MoA
PART 10: Geographical segmentation
PART 11: Decision framework
PART 12: Drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
Purchase this Premium Research Report at: http://www.reportsweb.com/buy&RW0001830867/buy/3500 . (Priced at US$ 3500).
Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Email: sam@reportsweb.com
Phone: +1-646-491-9876
Country: India
Website: http://www.reportsweb.com/global-antipsychotic-drugs-market-2017-2021